WELCOME TO
Predicting the effectiveness of chemotherapy in lung cancer patients with AI supported blood test
Ultra-high resolution glycan analysis and machine learning to predict the effectiveness of chemotherapy for lung cancer
Welcome to CheMOnitor, where we are advancing lung cancer treatment with our innovative AI-supported blood test. Our unique method (currently holding a patent pending status #P2400268), utilizes ultra-high resolution glycan analysis and machine learning to predict the effectiveness of chemotherapy for lung cancer. We are seeking for potential investors with experience in medtech – deeptech related fields. Please browse through our website to learn more about our solution and unique team.
Our Technology
Our AI-supported blood analysis platform uses advanced algorithm to
analyze blood samples to predict the effectiveness of chemotherapy for
lung cancer patients. This innovative approach aims to improve treatment outcomes and enhance patient survival by enabling doctors to make informed decisions and optimize treatment plans.
Why Glycan Analysis?
Glycans play a critical role in cancer biology. Our technology focuses on the analysis of these complex molecules to provide valuable insights that are crucial to understand patient response to chemotherapy.
AI Integration
By integrating AI with glycoanalytical tools, we generate and analyze vast amounts of data to identify unique patterns of N-glycan profiles that traditional methods might miss. This ensures a highly accurate and personalized approach to treatment planning.
Investors
Market potential
Lung cancer is the second most common cancer and the leading cause of cancer deaths worldwide. Each year, approximately 300,000 new cases are registered in the European Union and 61% of the patients are treated with chemotherapy.
By improving the prediction of chemotherapy effectiveness, we can improve treatment outcomes and reduce healthcare costs. The substantial number of patients requiring effective therapeutic solutions indicates a growing market with considerable opportunities for impact and expansion.
Why Invest in CheMOnitor?
CheMOnitor is contributing to the field of lung cancer therapy with its innovative solutions. Investing in our company means backing a breakthrough in personalized cancer treatment, with the potential to save lives and significantly reduce healthcare costs, offering substantial returns and market impact.
Get involved!
Join us in our mission to revolutionize cancer treatment. Contact us to learn more about investment opportunities and to become part of this transformative journey.
Get in touch!
To learn more about CheMOnitor and its innovative technology, please get in touch with us.
torokrebeka@gmail.com
PHONE
+36 30 3004042
ADDRESS
8200 Veszprem, Egyetem street 10.
TÖRÖK REBEKA
PROJECT LEADER
Graduated as a chemical/biotechnology engineer, now finishing her PhD in analytical chemistry. She has strong management skills gained from her private life by leading a wall climbing team of the university in more than five years.
PROF ANDRAS GUTTMAN
SCIENTIFIC ADVISOR
A prominent researcher in analytical chemistry, known for his outstanding contributions to the fields of glycomics and capillary electrophoresis. His leadership vision has led to the development of pioneering techniques for the analysis of complex biological molecules, which have gained him international recognition.
DR AGNES VATHY
DATA ANALYST
Agnes is an outstanding data mining scientist with 20 years of experience in computer assisted and AI-based data analytics systems. Pioneer in the application of deep learning techniques in chemistry. In her academic role, she serves as department chair and associate professor.
FELICIA "FELI" AUER
SENIOR DEVELOPER
Feli has a background in bioanalysis and is nearing the completion of her PhD thesis in the same field. She gained practical experience in the process analytical technology before returning to academia. Alongside her R&D career, she serves as vice-president of the university student council.
KINGA HOGYOR
JUNIOR DEVELOPER
Kinga holds a BSc in Biotechnology Engineering and is currently pursuing her MSc in Chemical Engineering. As a junior developer in the CheMOnitor project, she leverages her unique perspective and strong analytical skills to contribute effectively to the team.
DR MIKLÓS SZABÓ
MEDICAL ADVISOR
Miklos is a medical doctor specialized in clinical pulmonology and oncology with over 20 years of experience. Dr Szabo is also an active researcher, proven by his scientific track record.